Free tool
FAERS Monitor: Helium, Usp
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205912 or its brand name (Helium, Usp, Helium). Reports on generic versions are filed under their own applications.
Reports
50
Serious
46
92% of reports
Hospitalization
3
Death reported
33
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- completed suicide23
- asphyxia6
- overdose6
- toxicity to various agents5
- generalised tonic-clonic seizure4
- sedation4
- drug level increased3
- myalgia3
- off label use3
- abnormal behaviour2
- aggression2
- cataplexy2
- death2
- depression2
- diarrhoea2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2013 | 3 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 3 |
| 2017 | 11 |
| 2018 | 2 |
| 2019 | 8 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,109 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| cataplexy | 2 | 595.2 | 152.9 | 666 |
| asphyxiaSignal | 6 | 309.3 | 146.0 | 1,548 |
| completed suicideSignal | 23 | 116.1 | 86.0 | 2,521 |
| generalised tonic-clonic seizureSignal | 4 | 101.7 | 39.7 | 305 |
| drug level increasedSignal | 3 | 76.3 | 25.5 | 154 |
| sedationSignal | 4 | 64.3 | 25.1 | 190 |
| abnormal behaviour | 2 | 21.2 | 5.5 | 21 |
| aggression | 2 | 16.8 | 4.3 | 16 |
| toxicity to various agentsSignal | 5 | 12.5 | 5.4 | 42 |
| overdoseSignal | 6 | 11.7 | 5.5 | 49 |
| myalgiaSignal | 3 | 7.4 | 2.5 | 11 |
| depression | 2 | 3.7 | 1.0 | 2 |
| off label use | 3 | 1.4 | 0.5 | 0 |
| diarrhoea | 2 | 1.3 | 0.3 | 0 |
| death | 2 | 1.0 | 0.3 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.